Developments SL Science co-authors Biomedicines article on γδ T Cell Therapy in Glioblastoma SL Science Holding (NASDAQ: SLBT) has announced the publication of a peer-reviewed article in Biomedicines co-authored by SL Science leadership and clinical researchers from Taipei Medical University outlining a... August 11, 2026